NCT03623282View on ClinicalTrials.gov

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Bronchitis, COPD
Interventions
DRUG

Synatura® 15 mL

All subjects will receive Synatura® 15 mL every day three times for 3 months.

Trial Locations (1)

Unknown

Seoul St. Mary's hospital, Soeul

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT03623282 - Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD | Biotech Hunter | Biotech Hunter